Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1952 3
1953 3
1954 1
1956 1
1962 1
1964 2
1965 1
1966 1
1967 2
1968 2
1969 3
1970 3
1971 4
1972 7
1973 4
1975 37
1976 27
1977 24
1978 36
1979 31
1980 46
1981 58
1982 56
1983 82
1984 94
1985 108
1986 101
1987 118
1988 85
1989 132
1990 156
1991 149
1992 162
1993 145
1994 178
1995 203
1996 218
1997 250
1998 237
1999 281
2000 307
2001 293
2002 334
2003 316
2004 303
2005 354
2006 359
2007 367
2008 344
2009 377
2010 427
2011 476
2012 530
2013 534
2014 591
2015 569
2016 609
2017 594
2018 624
2019 624
2020 708
2021 851
2022 795
2023 732
2024 286

Text availability

Article attribute

Article type

Publication date

Search Results

13,716 results

Results by year

Filters applied: . Clear all
Page 1
Thrombotic microangiopathies of pregnancy: Differential diagnosis.
Gupta M, Feinberg BB, Burwick RM. Gupta M, et al. Pregnancy Hypertens. 2018 Apr;12:29-34. doi: 10.1016/j.preghy.2018.02.007. Epub 2018 Feb 16. Pregnancy Hypertens. 2018. PMID: 29674195 Review.
Thrombotic microangiopathy (TMA) disorders are characterized by microangiopathic hemolytic anemia, thrombocytopenia and end-organ injury. In pregnancy and postpartum, TMA is most commonly encountered with HELLP (hemolysis, elevated liver enzymes, low platelet count syndrom …
Thrombotic microangiopathy (TMA) disorders are characterized by microangiopathic hemolytic anemia, thrombocytopenia and end-organ inj …
Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management.
Hogan M, Berger JS. Hogan M, et al. Vasc Med. 2020 Apr;25(2):160-173. doi: 10.1177/1358863X19898253. Epub 2020 Mar 20. Vasc Med. 2020. PMID: 32195628 Review.
Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening complication of heparin exposure. ...
Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening complication of heparin exposure. ...
Diagnosing Immune Thrombocytopenia.
Sachs UJ. Sachs UJ. Hamostaseologie. 2019 Aug;39(3):250-258. doi: 10.1055/s-0039-1678739. Epub 2019 Feb 14. Hamostaseologie. 2019. PMID: 30763966 Review.
Although the detection of a characteristic autoantibody can prove immune thrombocytopenia (ITP), this diagnosis is often based on the exclusion of other causes of thrombocytopenia. ...It is therefore also useful to establish a diagnosis of (primarily) hyperdestructi …
Although the detection of a characteristic autoantibody can prove immune thrombocytopenia (ITP), this diagnosis is often based on the …
Phenotyping bleeding.
James P, Coller BS. James P, et al. Curr Opin Hematol. 2012 Sep;19(5):406-12. doi: 10.1097/MOH.0b013e32835673ab. Curr Opin Hematol. 2012. PMID: 22759628 Free PMC article. Review.
RECENT FINDINGS: New bleeding assessment tools (BATs) have been developed, firstly, to evaluate the relative bleeding risks associated with new anticoagulants and antiplatelet agents, secondly, to assess the efficacy of new thrombopoiesis stimulating agents in preventing hemorrha …
RECENT FINDINGS: New bleeding assessment tools (BATs) have been developed, firstly, to evaluate the relative bleeding risks associated with …
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.
Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Lo GK, et al. J Thromb Haemost. 2006 Apr;4(4):759-65. doi: 10.1111/j.1538-7836.2006.01787.x. J Thromb Haemost. 2006. PMID: 16634744 Free article.
As thrombocytopenia is common in hospitalized patients receiving heparin, it would be useful to have a clinical scoring system that could differentiate patients with HIT from those with other reasons for thrombocytopenia. ...CONCLUSIONS: A low pretest …
As thrombocytopenia is common in hospitalized patients receiving heparin, it would be useful to have a clinical scoring sys …
Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach.
Cuker A. Cuker A. Semin Thromb Hemost. 2014 Feb;40(1):106-14. doi: 10.1055/s-0033-1363461. Epub 2013 Dec 21. Semin Thromb Hemost. 2014. PMID: 24363239 Review.
Heparin-induced thrombocytopenia (HIT) is a clinicopathologic disorder that predisposes to thrombosis. ...Rapid and accurate diagnosis is paramount to avoid the perils of misdiagnosis. Clinical evaluation may be guided by scoring systems such as the 4Ts and H …
Heparin-induced thrombocytopenia (HIT) is a clinicopathologic disorder that predisposes to thrombosis. ...Rapid and accurate diagnosi …
Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis.
Pang Q, Qu K, Bi JB, Liu SS, Zhang JY, Song SD, Lin T, Xu XS, Wan Y, Tai MH, Liu HC, Dong YF, Liu C. Pang Q, et al. World J Gastroenterol. 2015 Jul 7;21(25):7895-906. doi: 10.3748/wjg.v21.i25.7895. World J Gastroenterol. 2015. PMID: 26167090 Free PMC article. Review.
AIM: To investigate the association between thrombocytopenia and relapse after treatment for hepatocellular carcinoma (HCC). ...In addition, no significant publication bias was detected. CONCLUSION: Thrombocytopenia before treatment might be an inexpensive and usefu …
AIM: To investigate the association between thrombocytopenia and relapse after treatment for hepatocellular carcinoma (HCC). ...In ad …
Abiraterone: thrombocytopenia.
[No authors listed] [No authors listed] Prescrire Int. 2014 Oct;23(153):241. Prescrire Int. 2014. PMID: 25964973 No abstract available.
Heparin-induced thrombocytopenia.
Greinacher A, Althaus K, Krauel K, Selleng S. Greinacher A, et al. Hamostaseologie. 2010 Jan;30(1):17-8, 20-8. Hamostaseologie. 2010. PMID: 20162249 Review.
Heparin-induced thrombocytopenia (HIT), typically occurring in the second week of heparin therapy, is an antibody-mediated adverse drug reaction associated with increased thrombotic risk. ...Thus, tests have a high negative, but only a moderate, positive predictive …
Heparin-induced thrombocytopenia (HIT), typically occurring in the second week of heparin therapy, is an antibody-mediated adverse dr …
DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S, Van Dyke D, Hanson C, Wu W, Pardanani A, Cervantes F, Passamonti F, Tefferi A. Gangat N, et al. J Clin Oncol. 2011 Feb 1;29(4):392-7. doi: 10.1200/JCO.2010.32.2446. Epub 2010 Dec 13. J Clin Oncol. 2011. PMID: 21149668
PURPOSE: The Dynamic International Prognostic Scoring System (DIPSS) for primary myelofibrosis (PMF) uses five risk factors to predict survival: age older than 65 years, hemoglobin lower than 10 g/dL, leukocytes higher than 25 10(9)/L, circulating blasts 1%, …
PURPOSE: The Dynamic International Prognostic Scoring System (DIPSS) for primary myelofibrosis (PMF) uses five risk factors to …
13,716 results
You have reached the last available page of results. Please see the User Guide for more information.